Company
HAL Allergy
- Biotech
- Founded:
- 1959
- Location:
- Leiden, Netherlands
- Parent:
- Droege Group
Description
HAL Allergy develops, manufactures, and distributes allergen immunotherapies, including subcutaneous and sublingual products, and produces modified allergen extracts for therapeutic and diagnostic use in allergic disease treatment and prevention, including pollen, house dust mite, and insect venom allergies.
HAL Allergy is located in the Netherlands ecosystem.
Related
ALK-Abelló A/SALK-Abelló A/S develops allergy immunotherapy treatments and management solutions using natural allergens, including grass pollen and house…
NTrans TechnologiesNTrans Technologies develops a non-viral delivery platform for cell and gene therapies, providing modular delivery solutions for…
ORCA TherapeuticsORCA Therapeutics develops oncolytic virus immunotherapies for prostate cancer, producing lead candidate ORCA-010 for treatment‑naive…
BIMINI BiotechBIMINI Biotech develops first-in-class small-molecule therapeutics targeting the Wiskott–Aldrich Syndrome protein for oncology and…
Molecular PartnersMolecular Partners develops DARPin therapeutics, including Radio-DARPins and logic-gated Switch-DARPins, to target DLL3, FAP x CD40, and…
GenDxGenDx provides NGS-based kits and software for HLA typing, chimerism monitoring, and KIR typing used in transplant diagnostics, combining…
AidianAidian develops, manufactures, and distributes CE‑marked in vitro diagnostic tests and point‑of‑care products for clinical diagnostics and…
CimCureCimCure develops cancer vaccines using its proprietary iBoost conjugate technology to induce immune responses that target and destroy…
Laigo BioLaigo Bio develops SureTACs, bispecific molecules that bind membrane targets and membrane E3 ligases to drive ubiquitin-mediated, lysosomal…